Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease

Published:2021-06-18 Issue:24 Volume:100 Page:e26340
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Ke,Liu Meng-Meng,Yang Xin,Chen Li,Geng Hui,Luo Wei,Ma Jie

Funder

Kunlun Elite, High-End Innovation and Entrepreneurship Talents of Qinghai Province

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference17 articles.

1. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults;O’Flaherty;Heart,2008

2. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan;Sekikawa;Trends Cardiovasc Med,2015

3. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors;Joseph;Circ Res,2017

4. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis;Skålén;Nature,2002

5. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications;Tabas;Circulation,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of rosuvastatin on serum asymmetric dimethylarginine levels and incidence of long-term cardiovascular events in patients with hyperlipidaemia and H-type hypertension;British Journal of Hospital Medicine;2024-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP